Jon S. - NYU’s Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence
Release Date: 02/11/2020
Psychedelics Today
Dylan Beynon: At-Home Ketamine Therapy, Big Pharma Pushback, and the Future of Psychedelic Accessibility In this episode, Joe Moore welcomes Dylan Beynon, CEO and Founder of , one of the largest providers of legal, at-home ketamine therapy in the U.S. Dylan shares the deeply personal story that led him to psychedelic medicine—including the tragic loss of his mother and sister to addiction and mental illness—and how these experiences continue to fuel his mission to make psychedelic therapy affordable and accessible for all. Mindbloom has now facilitated over 654,000 sessions across 38...
info_outlinePsychedelics Today
In this episode, we sit down with ., to discuss why the future of psychedelic access in the United States is being shaped not by federal agencies, but by the bold actions of individual states. As a legal scholar and writer focusing on drug policy, Victoria breaks down the significance of the FDA’s 2024 rejection of psychedelic-assisted therapy, and why that decision might be less of a setback than it seems. We explore how state-level initiatives like Oregon’s Psilocybin Services Act and Colorado’s Natural Medicine Health Act are setting the stage for a new model of access—one rooted...
info_outlinePsychedelics Today
info_outlinePsychedelics Today
info_outlinePsychedelics Today
Joe Moore and Anne Philippi are hosts of the PS25 Morning Show! This one features Dee Dee Goldpaugh, LCSW and Tommaso Barba, PhDC! We talk about all things Sex and Psychedelics!
info_outlinePsychedelics Today
n this episode of Psychedelics Today, kicking of Psychedelic Science 2025 week in Denver, we sit down with Jonathan Dicksinson, Chief Executive Officer, and Trevor Millar, Chief Operations Officer of Ambio Life Sciences – one of the world’s leading ibogaine clinics – to explore the potential of ibogaine for addiction, neuroregeneration, and how ethics, honoring experience, and sustainability will be key to delivering ibogaine at scale. Trevor shares his early work supporting marginalized populations in Vancouver’s Downtown Eastside, which led to the founding of Liberty Root, one...
info_outlinePsychedelics Today
In this episode of Psychedelics Today, hosts sit down with Jeff Breau from Harvard Divinity School's Center for the Study of World Religions. Key themes include the intersection of psychedelics and religion, harm reduction practices, and the burgeoning psychedelic church movement. Jeff brings insights from his ethnographic research on psychedelic churches and discusses the importance of interdisciplinary collaboration for advancing understanding in this field. He also delves into the role of music in psychedelic therapy, critiques of the Mystical Experience Questionnaire (MEQ), and the...
info_outlinePsychedelics Today
In this episode, Joe Moore sits down with from to discuss a range of fascinating topics. They begin by discussing the Harvard Divinity School and the CSWR’s mission and history. The conversation delves into the work and legacy of , a pivotal figure in the 1960s psychedelic harm reduction movement. It explores her contributions to the field through her Psychedelic Information Center. They also touch on the Quaker traditions and their intersection with LSD use, showing how spirituality and psychedelics can coalesce. Paul also talks about upcoming psychedelic and chaplaincy workshops,...
info_outlinePsychedelics Today
In this episode of Psychedelics Today, Joe Moore speaks with Dr. Simon Ruffell, a London-based psychiatrist, researcher, and curandero-in-training in the López Mahua lineage of the Shipibo tradition. Dr. Ruffell shares how his early fascination with psychiatry eventually led to a deep disillusionment with the limitations of conventional treatments—and a surprising pivot toward the Amazon. Now working at the intersection of Indigenous healing and clinical research, Ruffell describes his journey from medical school to shamanic apprenticeship. He offers insight into the Shipibo understanding...
info_outlinePsychedelics Today
Aspen Psychedelic Symposium 2024 – Hosted by Kevin Franciotti This powerful panel explores the healing potential and complex responsibilities that come with working with Ibogaine, a potent plant-based psychedelic. Moderator Kevin Franciotti guides a heartfelt and informative conversation with Talia Eisenberg, Tom Feegel, and Dr. Lola "Dr. O" Hoba, highlighting personal transformation, medical protocols, and the importance of honoring traditional knowledge. Personal Journeys with Ibogaine Talia Eisenberg shares her recovery from opioid addiction and the founding of BEOND Ibogaine, a medical...
info_outlineIn this episode, Joe interviews Jon S. on his experience in the psilocybin-assisted trials for alcohol dependency at NYU. In the show, they dive into Jon’s background and how psilocybin assisted therapy helped him out of his alcohol dependence and into a new life.
3 Key Points:
- Jon participated in the NYU Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence.
- The study was double-blind. In each session, he didn't know if he was going to receive psilocybin or Benadryl.
-
The sessions helped him so much with this dependence on alcohol, he believes he is a better father, husband, and human overall. He hasn't had a drink in 5 months (or a desire to).
Support the show
- Patreon
- Leave us a review on iTunes
- Share us with your friends – favorite podcast, etc
- Join our Facebook group - Psychedelics Today group – Find the others and create community.
Navigating Psychedelics
Show Notes
About Jon
- He is based in New York
- Jon is the father of 2 kids
- He spent a lot of his life DJing, so he has spent a lot of time around alcohol
- He found out about a psychedelic therapy study at NYU from someone at a Holotropic Breathwork Retreat
- The study took place in New York City
- He had always wanted to explore the psychedelic side of things
- He read Michael Pollan’s book and it said in the book that the Holotropic Breathwork community would be a great group to help find a guide
The Trial
- In his assessment, he found out truly how much he was drinking
- He would crack a beer before even playing with his kids
- He was into craft beer and at 8% a beer, his 3 beers were more like 5
- He was asked to not have his sessions recorded so he could be as open as he could be
- The session was very focused on curbing drinking
- His wife knew he was going down the path of psychedelic healing
- “I'm not doing this to have a good time, I'm doing this to be a better person” - Jon
- His trial was double-blind
- He was never told when he was receiving the psilocybin at each session
- He was told that he was either going to get 1 or 3 doses in the trial
The First Session
- The first session with the eye shades on (on psilocybin), was very visual
- In that first session he kept seeing this pirate ship underwater
- His sons would say “come on daddy, lets play on the pirate ship”
- He would go to the pirate ship with his sons and then say “I need to go back down and do some work”, and he would swim back into the depths
- He came home that day, and his youngest son greeted him at the door, and said let's play power rangers, I'll be the red power ranger and you be the pirate
- It hit him in a float tank session, the message of that session was to play with his sons more
- He had a moment in his first session of rebirth
Integration
- There is a 2 hour integration session the very next day
- He didn't think it was going to be as important as it turned out to be
- He had the choice to keep it at the same dose or up it
- He upped the dose to 40mg instead of 25mg
- He was told his second session wouldn't be anything like his first
- The medicine was so intense the second time, he couldn't even remember the music
- In his second session, he saw a body being chopped up (realizing it was his body)
- He realized that he was one with the universe, love is the only thing that matters
- He wanted to be a part of everything
- He was compensated about $100 per session
- "When the university gives you financial compensation, you buy everyone in the ice cream shop ice cream" - Jon
- Jon says he has a new baseline for anxiety
- He never thought he had anxiety, but after his sessions, he found that he is way less anxious than he was, even though he really wasn't
- He didn't have a desire to drink, he hasn't had a drink in 5 months
- He has never felt better or happier
- He's a much better dad, and husband
Life After the Experience
- He is re-reading Aldous Huxley and is finding a whole new meaning to it all
- He is spending more time with his family and being present with the
- He spends a ton of time with his kids now
- Stuff that used to worry him, doesn't worry him anymore
- His experience was everything he hoped for and more
- He genuinely believes, that whatever he got out of a session, is what he needed
Final Thoughts
- He is talking to the Decrim Nature in NY
- He appreciates the platform (Psychedelics Today) for the space to talk about his experience
- He appreciates everyone at NYU for the work they are doing

